Outlook Therapeutics Inc. (OTLK)
NASDAQ · Healthcare
Outlook Therapeutics Inc. Long Term Debt 2015–2025
Outlook Therapeutics Inc. annual long term debt history from 2015 to 2019. Long term debt refers to financial obligations that are due more than one year in the future.
- Outlook Therapeutics Inc. long term debt as of September 30, 2019: 1.08B, a 652426.26% increase year-over-year.
- Outlook Therapeutics Inc. long term debt for 2019 were 1.08B, a 652426.26% increase from 2018.
- Outlook Therapeutics Inc. long term debt for 2018 were 164,967, a 19.02% decrease from 2017.
- Outlook Therapeutics Inc. long term debt for 2017 were 203,710, a 92.93% decrease from 2016.
- Outlook Therapeutics Inc. long term debt for 2016 were 2.9M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Outlook Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2019 | $1,076 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $3 |
| 2015 | $3 |
Outlook Therapeutics Inc. Long Term Debt — FAQ
Outlook Therapeutics Inc. (OTLK) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OTLK's long term debt history?
The chart and table above show Outlook Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.